Overview

Analyses the international drug control regime, examining its legal foundations, emerging tensions, and the existing calls for reform in response to evolving challenges like synthetic drugs, cannabis legalisation, and new trafficking methods. This book critically examines the international drug control regime's legal framework, implementation challenges, and emerging tensions, exploring its failures, the debates on its modernisation, and potential reform pathways to address expanding drug markets, public health crises, and human rights concerns in a rapidly evolving global landscape.

Full Product Details

9781839995705

Table of Contents

Reviews

A critical examination of the international drug control regime, its legal foundations, growing tensions, and existing calls for reform in an era of emerging challenges such as synthetic drugs and cannabis legalization.. “At a moment of growing debate about the future of drug policy, Khalid Tinasti offers a careful, historically grounded account that avoids easy answers and instead provides the perspective needed for informed dialogue.” — José M. Zuniga, President & CEO, Fast- Track Health “Tinasti provides a clear and lucid account of the international drug control system. Unquestionably drugs remain a key global issue and this work serves as an important contribution to the literature on drug control's evolution and development.” — Mark Shaw, Director, Global Initiative against Transnational Organized Crime “Drawing on both scholarly depth and direct experience in international forums, Tinasti brings rare and valuable insights into the diplomacy of drug policy, illuminating the tensions and compromises that continue to shape one of the world’s most contested legal regimes.” — Julia Buxton, British Academy Global Professor, Liverpool John Moores University

Author Information

Khalid Tinasti is a research associate at the Centre on Conflict, Development and Peacebuilding at the Geneva Graduate Institute and a David F. Musto Visiting Scholar at the International Centre for Drug Policy Studies at Shanghai University.

Tab Content 6

Countries Available